Viracta Therapeutics Inc banner
V

Viracta Therapeutics Inc
NASDAQ:VIRX

Watchlist Manager
Viracta Therapeutics Inc
NASDAQ:VIRX
Watchlist
Price: 0.0098 USD Market Closed
Market Cap: $389.5k

Intrinsic Value

The intrinsic value for Viracta Therapeutics Inc (VIRX) under the Base Case is 0.0144 USD. Compared with the current market price of 0.0098 USD, the stock appears Undervalued by 32%.

VIRX Intrinsic Value
0.0144 USD
Undervaluation 32%
Intrinsic Value
Price $0.0098
V
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $0.01
Get notified when the price drops into your buy zone
Intrinsic Value $0.01
Margin of Safety 20% $0.01
Current Price $0.01
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about VIRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is VIRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Viracta Therapeutics Inc.

Explain Valuation
Alternatives to VIRX

Wall St
Price Targets

Dividends

Viracta Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

VIRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VIRX stock?

The intrinsic value for Viracta Therapeutics Inc (VIRX) under the Base Case is 0.0144 USD.

Is VIRX stock undervalued or overvalued?

Compared with the current market price of 0.0098 USD, the stock appears Undervalued by 32%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett